GWM
VXRT

Geneos Wealth Management’s Vaxart VXRT Stock Holding History

Geneos Wealth Management’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-200
Closed -$2K – 3131
2021
Q1 		$2K Hold
200
– – ﹤0.01% 2945
2020
Q4 		$1K Sell
200
-800
-80% -$5.09K ﹤0.01% 2842
2020
Q3 		$7K Buy
+1,000
New +$8.91K ﹤0.01% 2090

Other funds holding VXRT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geneos Wealth Management's VXRT Position: Q2 2021 in Review

Geneos Wealth Management sold out of Vaxart (VXRT) in Q2 2021, closing a stake of 200 shares — an estimated $2K sold.

Geneos Wealth Management first reported a position in VXRT in Q3 2020 and held it in 3 quarters. The position peaked at $7K in Q3 2020. 143 funds tracked by Wall St. Rank hold VXRT as of Q2 2021.

  • Geneos Wealth Management reported no remaining Vaxart position as of Q2 2021 after selling out during the quarter.
  • Geneos Wealth Management sold 200 Vaxart shares in Q2 2021, an estimated $2K.
  • Geneos Wealth Management first reported a position in Vaxart in Q3 2020 and held it in 3 quarters.
  • Geneos Wealth Management's Vaxart position peaked at $7K in Q3 2020.
  • 143 funds tracked by Wall St. Rank held Vaxart as of Q2 2021.

Based on Geneos Wealth Management's 13F filing for Q2 2021, filed 8 Jul 2021.